当前位置:首页 - 行情中心 - 宣泰医药(688247) - 财务分析 - 现金流量表

宣泰医药

(688247)

  

流通市值:49.60亿  总市值:49.60亿
流通股本:4.53亿   总股本:4.53亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金254,341,100.23165,603,473.12525,069,367.38369,844,520.06
  收到的税费返还5,433,086.32,819,547.3615,794,865.167,314,010.39
  收到其他与经营活动有关的现金2,774,751.24839,366.4516,436,077.6114,027,598.26
  经营活动现金流入小计262,548,937.77169,262,386.93557,300,310.15391,186,128.71
  购买商品、接受劳务支付的现金112,001,973.747,692,681.43253,733,552.39175,749,612.41
  支付给职工以及为职工支付的现金60,081,014.132,725,864.3488,015,961.2364,551,517.43
  支付的各项税费22,166,189.7211,962,919.5120,926,190.0212,348,884.7
  支付其他与经营活动有关的现金19,319,449.7311,292,717.9164,394,486.6450,706,365.64
  经营活动现金流出小计213,568,627.25103,674,183.19427,070,190.28303,356,380.18
  经营活动产生的现金流量净额48,980,310.5265,588,203.74130,230,119.8787,829,748.53
二、投资活动产生的现金流量:
  收回投资收到的现金945,800,000376,900,0002,172,011,2501,424,011,250
  取得投资收益收到的现金4,197,837.741,055,934.710,980,028.127,004,971.12
  投资活动现金流入小计949,997,837.74377,955,934.72,182,991,278.121,431,016,221.12
  购建固定资产、无形资产和其他长期资产支付的现金25,756,866.5517,570,486.1394,931,988.8741,586,694.25
  投资支付的现金971,100,000502,777,7202,571,900,0001,767,000,000
  投资活动现金流出小计996,856,866.55520,348,206.132,666,831,988.871,808,586,694.25
  投资活动产生的现金流量净额-46,859,028.81-142,392,271.43-483,840,710.75-377,570,473.13
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金18,374,090.72-27,879,460.0618,415,309.53
  支付其他与筹资活动有关的现金51,083.7616,840.836,215,478.8236,215,478.82
  筹资活动现金流出小计18,425,174.4816,840.864,094,938.8854,630,788.35
  筹资活动产生的现金流量净额-18,425,174.48-16,840.8-64,094,938.88-54,630,788.35
四、汇率变动对现金及现金等价物的影响-431,027.64-9,010.921,707,502.49223,673.98
五、现金及现金等价物净增加额-16,734,920.41-76,829,919.41-415,998,027.27-344,147,838.97
  加:期初现金及现金等价物余额225,785,781.43225,785,781.43641,783,808.7641,783,808.7
  期末现金及现金等价物余额209,050,861.02148,955,862.02225,785,781.43297,635,969.73
补充资料:
  净利润45,585,665.46-127,700,550.17-
  资产减值准备1,014,367.59--1,621,752.05-
  固定资产和投资性房地产折旧11,082,567.18-18,006,349.49-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,082,567.18-18,006,349.49-
  无形资产摊销3,385,877.77-6,764,396.31-
  长期待摊费用摊销274,020.29-619,413.37-
  固定资产报废损失--592,615.77-
  财务费用334,006.56--2,064,924.51-
  投资损失-6,662,038.67--11,001,147.36-
  递延所得税498,013.92--5,184,416.39-
  其中:递延所得税资产减少569,811.79--5,044,633.97-
    递延所得税负债增加-71,797.87--139,782.42-
  存货的减少896,176.65--16,455,897.08-
  经营性应收项目的减少27,750,904.8--25,276,723.31-
  经营性应付项目的增加-26,412,014.21-17,530,279.74-
  其他-7,105,091.64-16,631,332.97-
  现金的期末余额209,050,861.02-225,785,781.43-
  减:现金的期初余额225,785,781.43-641,783,808.7-
  现金及现金等价物的净增加额-16,734,920.41--415,998,027.27-
公告日期2025-08-232025-04-302025-04-302024-10-30
审计意见(境内)标准无保留意见
TOP↑